1.
Sci Transl Med
; 16(763): eabq7378, 2024 Sep 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-39231242
RESUMO
Elucidating optimal vaccine adjuvants for harnessing age-specific immune pathways to enhance magnitude, breadth, and durability of immunogenicity remains a key gap area in pediatric vaccine design. A better understanding of age-specific adjuvants will inform precision discovery and development of safe and effective vaccines for protecting children from preventable infectious diseases.